Berberine Improves Glucose and Lipid Metabolism in HepG2 Cells Through AMPKα1 Activation

Gang Ren(Chinese Academy of Medical Sciences & Peking Union Medical College), Jian‐Dong Jiang(Chinese Academy of Medical Sciences & Peking Union Medical College)
Frontiers in Pharmacology
May 8, 2020
10.3389/fphar.2020.00647
Cited by 47

Related Papers

Bioactivities of berberine metabolites after transformation through CYP450 isoenzymes
|Journal of Translational Medicine|2011|104
Liver-target nanotechnology facilitates berberine to ameliorate cardio-metabolic diseases
|Nature Communications|2019|74
Berberine stimulates lysosomal AMPK independent of PEN2 and maintains cellular AMPK activity through inhibiting the dephosphorylation regulator UHRF1
|Frontiers in Pharmacology|2023|14